BioCentury
ARTICLE | Clinical News

Oxycodone/naltrexone regulatory update

July 25, 2016 7:00 AM UTC

FDA issued a complete response letter to Elite for an NDA for SequestOx oxycodone/naltrexone to manage moderate to severe pain where the use of an opioid analgesic is appropriate. The agency said the ...